Rakhmanina, Natella
Title | Professor |
---|
Institution | Childrens National Medical Center |
---|
Department | Infectious Diseases |
---|
Address | 111 Michigan Ave NW Washington DC 20010
|
---|
Phone | (202) 4762083 |
---|
vCard | Download vCard |
---|
|
|
|
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Corrigan B, Mukui I, Mulenga L, Mthethwa N, Letsie M, Bruno S, Rakhmanina N. Characteristics of Treatment-experienced HIV-infected African Children and Adolescents Initiating Darunavir and/or Etravirine-based Antiretroviral Treatment. Pediatr Infect Dis J. 2018 Jul; 37(7):669-672. PMID: 29140932.
-
Rakhmanina N, Siberry GK. In Search of the Right Time and Right Place: Screening Adolescents and Youth for Human Immunodeficiency Virus in the United States. J Adolesc Health. 2018 Jan; 62(1):3-4. PMID: 29133023.
-
Dubrocq G, Estrada A, Kelly S, Rakhmanina N. Acute development of Cushing syndrome in an HIV-infected child on atazanavir/ritonavir based antiretroviral therapy. Endocrinol Diabetes Metab Case Rep. 2017; 2017. PMID: 29118985.
-
Ruria EC, Masaba R, Kose J, Woelk G, Mwangi E, Matu L, Ng'eno H, Bikeri B, Rakhmanina N. Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection. AIDS. 2017 07 01; 31 Suppl 3:S253-S260. PMID: 28665883.
-
Williams EF, Ferrer K, Lee MA, Bright K, Williams K, Rakhmanina NY. Growing up with perinatal human immunodeficiency virus-A life not expected. J Clin Nurs. 2017 Dec; 26(23-24):4734-4744. PMID: 28334487.
-
Dubrocq G, Rakhmanina N, Phelps BR. Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients. Paediatr Drugs. 2017 Apr; 19(2):91-98. PMID: 28074348.
-
Greene E, Pack A, Stanton J, Shelus V, Tolley EE, Taylor J, El Sadr WM, Branson BM, Leider J, Rakhmanina N, Gamble T. "It Makes You Feel Like Someone Cares" acceptability of a financial incentive intervention for HIV viral suppression in the HPTN 065 (TLC-Plus) study. PLoS One. 2017; 12(2):e0170686. PMID: 28182706.
-
Rakhmanina N, Lam KS, Hern J, Young HA, Walters A, Castel AD. Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA. J Int AIDS Soc. 2016; 19(1):20936. PMID: 27797320.
-
Gaur AH, Kizito H, Prasitsueubsai W, Rakhmanina N, Rassool M, Chakraborty R, Batra J, Kosalaraksa P, Luesomboon W, Porter D, Shao Y, Myers M, Ting L, SenGupta D, Quirk E, Rhee MS. Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial. Lancet HIV. 2016 12; 3(12):e561-e568. PMID: 27765666.
-
Castel AD, Kalmin MM, Hart RL, Young HA, Hays H, Benator D, Kumar P, Elion R, Parenti D, Ruiz ME, Wood A, D'Angelo L, Rakhmanina N, Rana S, Bryant M, Hebou A, Fernández R, Abbott S, Peterson J, Wood K, Subramanian T, Binkley J, Happ LP, Kharfen M, Masur H, Greenberg AE. Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care - Washington, DC. AIDS Care. 2016 11; 28(11):1355-64. PMID: 27297952.
-
Rakhmanina N, Wong EC, Davis JC, Ray PE. Hemorrhagic Stroke in an Adolescent Female with HIV-Associated Thrombotic Thrombocytopenic Purpura. J AIDS Clin Res. 2014 Jun; 5(6). PMID: 25429351.
-
Rakhmanina NY, van den Anker JN. Pharmacologic prevention of perinatal HIV infection. Early Hum Dev. 2014 Mar; 90 Suppl 1:S13-5. PMID: 24709447.
-
Rakhmanina N, Messenger N, Phillips G, Teach S, Morrison S, Hern J, Payne J, Ganesan K, Castel AD. Factors affecting acceptance of routine human immunodeficiency virus screening by adolescents in pediatric emergency departments. J Adolesc Health. 2014 Feb; 54(2):176-82. PMID: 24060572.
-
Kirmse B, Baumgart S, Rakhmanina N. Metabolic and mitochondrial effects of antiretroviral drug exposure in pregnancy and postpartum: implications for fetal and future health. Semin Fetal Neonatal Med. 2013 Feb; 18(1):48-55. PMID: 23164810.
-
Rakhmanina N, Phelps BR. Pharmacotherapy of pediatric HIV infection. Pediatr Clin North Am. 2012 Oct; 59(5):1093-115. PMID: 23036246; PMCID: PMC3465562.
-
Rakhmanina NY, Dirajlal-Fargo S, Capparelli EV, Mirochnik M. Pharmacokinetic considerations of perinatal antiretroviral therapy. Curr Drug Metab. 2012 Jul; 13(6):744-59. PMID: 22452457.
-
Rakhmanina NY, Neely MN, Capparelli EV. High dose of darunavir in treatment-experienced HIV-infected adolescent results in virologic suppression and improved CD4 cell count. Ther Drug Monit. 2012 Jun; 34(3):237-41. PMID: 22549499; PMCID: PMC3354040.
-
Ivy W, Dominguez KL, Rakhmanina NY, Iuliano AD, Danner SP, Borkowf CB, Denson AP, Gaur AH, Mitchell CD, Henderson SL, Paul ME, Barton T, Herbert-Grant M, Hader SL, Pérez García E, Malachowski JL, Nesheim SR. Premastication as a route of pediatric HIV transmission: case-control and cross-sectional investigations. J Acquir Immune Defic Syndr. 2012 Feb 01; 59(2):207-12. PMID: 22027873.
-
Best BM, Capparelli EV, Diep H, Rossi SS, Farrell MJ, Williams E, Lee G, van den Anker JN, Rakhmanina N. Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children. J Acquir Immune Defic Syndr. 2011 Dec 01; 58(4):385-91. PMID: 21876444; PMCID: PMC3205189.
-
Rakhmanina NY, Neely MN, Van Schaik RH, Gordish-Dressman HA, Williams KD, Soldin SJ, van den Anker JN. CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children. Ther Drug Monit. 2011 Aug; 33(4):417-24. PMID: 21743379; PMCID: PMC3139013.
-
Phelps BR, Rakhmanina N. Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges. Paediatr Drugs. 2011 Jun 01; 13(3):175-92. PMID: 21500872.
-
Neely MN, Rakhmanina NY. Pharmacokinetic optimization of antiretroviral therapy in children and adolescents. Clin Pharmacokinet. 2011 Mar; 50(3):143-89. PMID: 21294595.
-
Rakhmanina NY, van den Anker JN, Soldin SJ, van Schaik RH, Mordwinkin N, Neely MN. Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents? Ther Drug Monit. 2010 Jun; 32(3):273-81. PMID: 20445485; PMCID: PMC2886015.
-
Neely MN, Rakhmanina NY. Comment on: Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children. J Antimicrob Chemother. 2010 Apr; 65(4):808-9; author reply 809-10. PMID: 20086000.
-
Rakhmanina NY, van den Anker JN. Treating an HIV-infected paediatric patient: an easy task? Antivir Ther. 2010; 15(3):293-6. PMID: 20516549.
-
Rakhmanina NY, van den Anker JN. Efavirenz in the therapy of HIV infection. Expert Opin Drug Metab Toxicol. 2010 Jan; 6(1):95-103. PMID: 20001610; PMCID: PMC2810555.
-
Soler-García AA, Rakhmanina NY, Mattison PC, Ray PE. A urinary biomarker profile for children with HIV-associated renal diseases. Kidney Int. 2009 Jul; 76(2):207-14. PMID: 19357719; PMCID: PMC2778294.
-
Rakhmanina N, van den Anker J, Baghdassarian A, Soldin S, Williams K, Neely MN. Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children. Antimicrob Agents Chemother. 2009 Jun; 53(6):2532-8. PMID: 19258274; PMCID: PMC2687254.
-
Rakhmanina NY, Sill A, Baghdassarian A, Bruce K, Williams K, Castel AD, Rakusan T, Singh N, Spiegel HM. Epidemiology of new cases of HIV-1 infection in children referred to the metropolitan pediatric hospital in Washington, DC. Pediatr Infect Dis J. 2008 Sep; 27(9):837-9. PMID: 18664925.
-
Rakhmanina NY, Capparelli EV, van den Anker JN, Williams K, Sever JL, Spiegel HM, Soldin SJ. Nevirapine concentration in nonstimulated saliva: an alternative to plasma sampling in children with human immunodeficiency virus infection. Ther Drug Monit. 2007 Feb; 29(1):110-7. PMID: 17304158.
-
Rakhmanina NY, van den Anker JN. Pharmacological research in pediatrics: From neonates to adolescents. Adv Drug Deliv Rev. 2006 Apr 20; 58(1):4-14. PMID: 16533543.
-
Capparelli E, Rakhmanina N, Mirochnick M. Pharmacotherapy of perinatal HIV. Semin Fetal Neonatal Med. 2005 Apr; 10(2):161-75. PMID: 15701581.
-
Soldin SJ, Rakhmanina NY, Spiegel HM, Sever JL. Therapeutic drug monitoring for patients with HIV infection: Children's National Medical Center, Washington DC experience. Ther Drug Monit. 2004 Apr; 26(2):107-9. PMID: 15228148.
-
Rakhmanina NY, van den Anker JN, Soldin SJ. Safety and pharmacokinetics of antiretroviral therapy during pregnancy. Ther Drug Monit. 2004 Apr; 26(2):110-5. PMID: 15228149.
-
Fraaij PL, Rakhmanina N, Burger DM, de Groot R. Therapeutic drug monitoring in children with HIV/AIDS. Ther Drug Monit. 2004 Apr; 26(2):122-6. PMID: 15228151.
-
Rakhmanina NY, van den Anker JN, Soldin SJ. Therapeutic drug monitoring of antiretroviral therapy. AIDS Patient Care STDS. 2004 Jan; 18(1):7-14. PMID: 15006189.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2004 | 4 | 2005 | 1 | 2006 | 1 | 2007 | 1 | 2008 | 1 | 2009 | 2 | 2010 | 4 | 2011 | 4 | 2012 | 5 | 2013 | 1 | 2014 | 2 | 2016 | 3 | 2017 | 6 | 2018 | 1 |
To return to the timeline, click here.
|
Rakhmanina's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|